In a trading update at its Annual General Meeting, Porvair confirmed that underlying revenue was 7% ahead of last year. Aerospace, US industrial and Seal Analytical all performed well. The company’s progress towards commissioning large projects continues on track with very little revenue recognised compared with the prior period, as expected.
Porvair says that order books for the balance of the year are healthy.
Earlier this month, Porvair announced the acquisition of J G Finneran Associates Inc, a US manufacturer and distributor of specialist laboratory consumables including filters, vials, microplates, closures and ancillary products.
Porvair will announce its interim results for the six months ending 31 May 2017 on 27 June 2017.
